FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5322511000001102: Generic Stalevo 50mg/12.5mg/200mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
15693501000001112 Generic Stalevo 50mg/12.5mg/200mg tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
96737301000001117 Levodopa 50mg / Carbidopa 12.5mg / Entacapone 200mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


12 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Generic Stalevo 50mg/12.5mg/200mg tablets Count of base of active ingredient 3 false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Is a Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Is a Levodopa + Carbidopa + Entacapone true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has active ingredient Entacapone false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Plays role Antiparkinson therapeutic role true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has specific active ingredient Carbidopa true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has specific active ingredient Entacapone true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Stalevo 50mg/12.5mg/200mg tablets (Orion Pharma (UK) Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets 100 tablet Is pack of False Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets 30 tablet Is pack of False Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Sastravi 50mg/12.5mg/200mg tablets (Accord Healthcare Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (PI) (Waymade Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Dowelhurst Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Doncaster Pharmaceuticals Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Sigma Pharmaceuticals Plc) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets 100 tablet Has VMP True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets 30 tablet Has VMP True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Lexon (UK) Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Mawdsley-Brooks & Company Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Necessity Supplies Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Sastravi 50mg/12.5mg/200mg tablets (Actavis UK Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stanek 50mg/12.5mg/200mg tablets (Teva UK Ltd) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Originalis B.V.) Is a True Generic Stalevo 50mg/12.5mg/200mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start